CIK 0001595248 · Non-accelerated filer<br>Smaller reporting company
Genprex, Inc.
Sign in to watch- Ticker
- GNPX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 900772347
- Phone
- 512-537-7997
- Business address
- 3300 BEE CAVE ROAD SUITE 650-227, AUSTIN, TX, 78746
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-18 | Confer Ryan M. Chief Financial Officer | Shares withheld for taxes | −1,126 | $4.40 | $5K | 9,763 |
| 2023-06-27 | Moreno Toscano Jose Antonio Director | Grant or award | +123,795 | 123,795 | ||
| 2023-06-27 | LONGNECKER BRENT M Director | Grant or award | +123,795 | 138,795 | ||
| 2023-06-27 | Wilson William R Jr. Director | Grant or award | +123,795 | 123,795 | ||
| 2023-04-21 | Varner John Rodney Chairman, President and CEO | Purchase | +19,000 | $1.06 | $20K | 20,800 |
| 2023-04-21 | VACZY CATHERINE M EVP GC Chief Strategy Officer | Purchase | +20,000 | $1.07 | $21K | 265,000 |
| 2023-02-18 | VACZY CATHERINE M EVP GC Chief Strategy Officer | Grant or award | +245,000 | 245,000 | ||
| 2023-02-18 | Berger Mark Stanley Chief Medical Officer | Grant or award | +245,000 | 245,000 | ||
| 2023-02-18 | Kumar Hermant Chief Mfgr & Tech Officer | Grant or award | +200,000 | 200,000 | ||
| 2023-02-18 | Confer Ryan M. Chief Financial Officer | Grant or award | +245,000 | 435,499 | ||
| 2023-02-18 | Varner John Rodney President & CEO | Grant or award | +625,000 | 1,159,735 | ||
| 2022-07-28 | Confer Ryan M. Chief Financial Officer | Option exercise | +116,973 | $0.02 | $2K | 190,499 |
| 2022-07-28 | Confer Ryan M. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −116,973 | 0 | ||
| 2022-06-23 | Moreno Toscano Jose Antonio Director | Grant or award · Stock Option (right to buy) | +83,368 | 83,368 | ||
| 2022-06-23 | LONGNECKER BRENT M Director | Grant or award · Stock Option (right to buy) | +83,368 | 83,368 | ||
| 2022-06-23 | Wilson William R Jr. Director | Grant or award · Stock Option (right to buy) | +83,368 | 83,368 | ||
| 2022-06-23 | Kumar Hermant Chief Mfgr & Tech Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2022-02-04 | VACZY CATHERINE M EVP GC Chief Strategy Officer | Grant or award · Stock Option (right to buy) | +325,000 | 325,000 | ||
| 2022-02-04 | Confer Ryan M. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +341,750 | 341,750 | ||
| 2022-02-04 | Varner John Rodney President & CEO | Grant or award · Stock Option (right to buy) | +1,062,250 | 1,062,250 |
Page 2 of 5 · 88 trades